ArticleNuclear medicine communications2019

The BRAFV600E mutation in papillary thyroid microcarcinoma with intermediate-risk to high-risk features: does the mutation have an effect on clinical response to radioiodine therapy?

Guohua Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.